In October 1949, the Nobel Committee in Stockholm awarded the Prize in Physiology or Medicine to António Egas Moniz, a Portuguese neurologist, for his discovery of “the therapeutic value of leucotomy in certain psychoses.” Leucotomy — better known today as the lobotomy — involved severing the connections between the frontal lobes and the rest of the brain. Moniz had performed his first procedure in 1935. By 1949, tens of thousands of lobotomies had been performed worldwide. By the time the procedure was effectively abandoned in the late 1950s and 1960s, the number exceeded 100,000.
The Nobel Prize is the most prestigious award in science. It is not given lightly, and it is never rescinded — a policy the Nobel Committee has maintained even as medical consensus on Moniz’s prize has collapsed entirely. There have been periodic calls to revoke the award, all declined. The lobotomy’s Nobel stands as the starkest monument in modern medicine to the gap between institutional recognition and actual therapeutic value, and it demands an explanation: how did a procedure that left patients diminished, docile, and in many cases permanently damaged come to be considered a medical triumph?
The answer involves a psychiatric system overwhelmed beyond its capacity, a scientific culture that mistook observed change for improvement, a charismatic American promoter whose energy outran his judgment, and a Nobel Committee that made its decision faster than the evidence warranted. None of these factors alone would have been sufficient. Together, they produced one of the most damaging episodes in the history of medicine.
Contents
The Crisis That Made Lobotomy Thinkable
To understand why the lobotomy seemed like a solution, you have to understand the problem it claimed to solve. In the first half of the 20th century, psychiatric hospitals — then called asylums — were in a state of catastrophic overcrowding. The United States alone had over 400,000 people institutionalized by the late 1930s, and the number was growing. The hospitals were understaffed, underfunded, and without effective treatments for the conditions most of their patients presented: schizophrenia, severe depression, bipolar disorder, and what was then called “chronic agitation.”
The Treatment Vacuum
The therapeutic options available to psychiatrists in the 1930s were limited and largely ineffective. Insulin coma therapy — inducing coma through massive insulin doses — was in use, with claimed benefits that were never convincingly demonstrated in controlled trials. Metrazol convulsive therapy produced seizures through chemical injection and was deeply unpleasant for patients. Electroconvulsive therapy (ECT) had just been introduced in 1938 and would eventually prove genuinely effective for severe depression, but was at this stage poorly understood and inconsistently applied. For schizophrenia, the condition that filled most asylum beds, there was essentially nothing that worked. Chlorpromazine, the first antipsychotic drug, would not be introduced until 1952. The asylum system was warehousing people it could not treat, in conditions that were often squalid and sometimes brutal, with no scientific basis for hope of improvement.
The Theoretical Basis for Surgery
It was into this void that Egas Moniz stepped with a theory derived partly from animal research and partly from a presentation he attended at the Second International Neurological Congress in London in 1935. Yale researchers John Fulton and Carlyle Jacobsen presented work on chimpanzees whose frontal lobes had been surgically removed. The animals had previously shown frustration and agitation when they made errors in experimental tasks; after the surgery, they no longer appeared distressed by failure. One of the chimps, named Becky, had been particularly anxious before; afterward she was placid. Moniz reportedly stood up after the presentation and asked whether a similar operation might benefit humans with anxiety and obsessive states. Fulton was reportedly alarmed by the suggestion. Moniz proceeded anyway.
His theoretical framework was that certain mental illnesses were maintained by fixed, pathological patterns of neural connectivity in the frontal lobes — “fixed ideas,” in his terminology — and that severing those connections would free the patient from the pathological loop. The theory had no rigorous experimental basis and rested on an analogy between chimpanzee behavior in a laboratory task and human psychiatric illness that was, at minimum, a large leap. But it was a theory, which was more than most of his contemporaries had, and it pointed toward action at a moment when the psychiatric profession desperately wanted something to do.
Moniz, Freeman, and the Spread of the Procedure
Moniz performed his first leucotomy in November 1935, drilling holes in the skull and injecting ethanol to destroy frontal lobe tissue, later developing a specialized instrument called the leucotome to sever the fibers more precisely. He reported results in 20 patients, claiming improvement in the majority. His evaluation criteria were loose: “improvement” was defined largely as reduced agitation and more manageable behavior, assessed by the operating surgeon with no independent evaluation, no control group, and no systematic follow-up. By modern standards, the evidence base was essentially nonexistent. By the standards of 1930s psychiatry, it was enough to attract serious attention.
Walter Freeman and the Transorbital Lobotomy
The procedure reached its widest application through Walter Freeman, an American neurologist at George Washington University who became its most energetic and ultimately most destructive advocate. Freeman was not a surgeon — he held no surgical qualifications — but he learned the leucotomy technique from his colleague James Watts and began performing it in 1936. He was a gifted promoter with a genuine belief in the procedure’s benefits, and he traveled relentlessly, demonstrating and teaching it across the United States.
In 1945, Freeman developed a modified technique that would remove the last remaining obstacles to mass adoption. The transorbital lobotomy required no surgical theater, no general anesthesia, and no neurosurgical training. Freeman inserted an ice pick-like instrument — initially a literal ice pick from his kitchen; later a purpose-built orbitoclast — through the thin bone of the eye socket, above the eyeball, and swept it back and forth to sever the frontal connections. The procedure took minutes. Freeman performed it in his office, in state hospital wards, occasionally in the back of his van, which he called the “lobotomobile.” He is estimated to have performed or supervised approximately 3,500 lobotomies over his career. He kept meticulous photographic records and was known to perform multiple procedures in a single day before an audience of hospital staff and visiting physicians.
The Institutional Embrace
The speed with which the lobotomy spread through American psychiatry reflects how badly the profession needed something that appeared to work. State hospitals facing catastrophic overcrowding saw the procedure as a management tool as much as a treatment: lobotomized patients were calmer, more compliant, and easier to discharge. Freeman actively promoted the procedure to state hospital administrators on exactly those grounds — that it would reduce the chronic patient population and cut institutional costs. Between 1949 and 1952, at the peak of the lobotomy era, an estimated 5,000 procedures were performed annually in the United States alone.
What the Lobotomy Actually Did
The honest accounting of what lobotomy did to patients requires separating two things that the procedure’s advocates consistently conflated: the reduction of disturbing behavior, and genuine therapeutic benefit. The lobotomy reliably produced the former. It almost never produced the latter.
The Nature of the Damage
The frontal lobes are the most recently evolved region of the human brain and are central to what neurologists call executive function: planning, decision-making, impulse control, the ability to anticipate consequences, emotional regulation, and the integration of past experience with present action. Severing the connections between the frontal lobes and the rest of the brain does not eliminate these capacities entirely, but it substantially degrades them. Lobotomized patients frequently became passive, emotionally blunted, and unable to plan or initiate purposeful activity. They might appear calm because they had lost the cognitive machinery for distress, not because their underlying condition had been treated.
The neurologist Elliot Valenstein, who conducted one of the most thorough historical analyses of the lobotomy era in his 1986 book Great and Desperate Cures, documented the systematic pattern: patients who had been acutely agitated became manageable, which was recorded as improvement. Whether they retained their personalities, their capacity for relationships, their ability to work or care for themselves — these outcomes were rarely systematically assessed. When they were, the findings were troubling. Many patients who were discharged as “improved” required re-institutionalization within years. Many who remained outside institutions did so in a condition of profound diminishment that their families often found worse than the original illness.
The Most Famous Victim
Rosemary Kennedy, the sister of President John F. Kennedy, received a lobotomy in 1941 at the age of 23, performed by Walter Freeman and James Watts at her father Joseph Kennedy’s direction. Joseph Kennedy arranged the procedure without informing Rosemary’s mother. The stated justification was her increasingly erratic behavior and mood swings, which her family found difficult to manage. The result was catastrophic: Rosemary was left with the mental capacity of a two-year-old, incontinent, unable to speak coherently, and requiring full-time institutional care for the rest of her life. She died in 2005. The Kennedy family concealed what had happened to her for decades; her existence was not publicly acknowledged until the 1960s.
Rosemary’s case was not typical in its severity, but it was not as exceptional as the lobotomy’s advocates would have preferred. Freeman’s own records, examined by historians, show a significant proportion of patients with outcomes that were catastrophic by any reasonable measure. He classified many of them as successes nonetheless.
How the Nobel Prize Happened
The Nobel Committee’s decision to award Moniz the prize in 1949 has been examined by historians of medicine with a mixture of bafflement and reconstructed explanation. The committee was working from published literature that was, by the standards of the time, substantial: Moniz and others had published extensively on leucotomy, and the reports were predominantly positive. The methodological problems — no control groups, no independent assessment, no systematic follow-up, outcome measures defined entirely as behavioral manageability — were characteristic of psychiatric research of the period, not anomalies that would have stood out to evaluators accustomed to that literature.
There is also a timing issue that the committee could not have known. The Nobel was awarded in 1949; chlorpromazine, which would transform psychiatric treatment and effectively make the lobotomy obsolete, was introduced in 1952. The committee was making a decision at what turned out to be the peak of the lobotomy era, before the evidence of its harms had accumulated in the literature and before better alternatives existed to make the comparison damning. By 1955, the picture looked very different. By 1960, it was clear that the procedure had been a catastrophe. By 1949, it had not yet fully revealed itself as one.
The End of the Lobotomy Era
The lobotomy did not end with a single moment of reckoning. It ended through a combination of pharmaceutical displacement, accumulating evidence of harm, changing psychiatric culture, and the eventual disgrace of its most prominent advocate.
Chlorpromazine and the Pharmacological Revolution
The introduction of chlorpromazine in 1952 changed everything. The drug, initially developed as an anesthetic adjunct, was found by the French psychiatrists Jean Delay and Pierre Deniker to produce a striking calming effect in acutely psychotic patients without sedation — patients could be rendered manageable while remaining conscious and communicative. It was not a cure for schizophrenia, but it was a treatment, and it was reversible, which the lobotomy was not. Psychiatrists who had been performing lobotomies because they had nothing better available now had something better available. Adoption of antipsychotic medication was rapid, and lobotomy rates fell sharply through the mid-1950s.
Walter Freeman’s Final Disgrace
Freeman continued performing lobotomies long after the medical consensus had shifted against him. His professional relationship with James Watts ended in the early 1950s in part over Freeman’s insistence on performing transorbital lobotomies without surgical supervision. He lost his hospital operating privileges at George Washington University in 1954. He continued operating at other institutions. In 1967, at the age of 72, he performed a lobotomy on a patient named Helen Mortensen — the third lobotomy he had performed on her. She died of a brain hemorrhage. Freeman’s operating privileges were revoked permanently, and he retired. He died in 1972, still believing, by most accounts, in the value of the work he had done.
The Legal and Ethical Reckoning
The broader reckoning with the lobotomy era fed directly into the patient rights movement of the 1960s and 1970s and into the development of modern medical ethics around informed consent. Many of the lobotomies performed at the peak of the era were done without anything resembling genuine consent: patients in state hospitals were not in a position to refuse, and in many cases their families consented on their behalf without being fully informed of the risks. The recognition that this had happened — that a procedure causing permanent brain damage had been performed on hundreds of thousands of people with inadequate evidentiary basis and insufficient regard for their autonomy — was one of the forcing events that produced the stricter consent requirements and institutional review board oversight that govern medical research and practice today.
What the Lobotomy Era Means
The lobotomy story is sometimes used as a simple cautionary tale about scientific hubris, but the reality is more instructive and more uncomfortable than that. Most of the people who promoted and performed lobotomies were not villains. Moniz was a serious neurologist who made other genuine contributions, including the development of cerebral angiography. Freeman was, by the accounts of people who knew him, a man who genuinely believed he was helping his patients. The psychiatrists who adopted the procedure were responding to a genuine crisis with the best tools they believed they had.
The catastrophe happened not because bad people did bad things but because good people operated within a system that lacked the mechanisms to catch a bad idea. There were no randomized controlled trials. There was no requirement for independent outcome assessment. The outcome measure — behavioral manageability — was defined by the people who had the most to gain from a positive result. The patients who were harmed were among the most vulnerable and least powerful people in society, housed in institutions that were structurally indifferent to their preferences and wellbeing.
What changed was not human nature but scientific infrastructure. The randomized controlled trial, the requirement for independent replication, the systematic follow-up, the ethics board, the informed consent requirement — these are not bureaucratic inconveniences. They are the error-correction mechanisms that the lobotomy era demonstrated were necessary, in the hardest possible way. Medicine before those mechanisms was capable of awarding a Nobel Prize for a procedure that was making patients worse. Medicine after them is not immune to error, but it is considerably harder for a bad idea to travel as far and as fast as the lobotomy did between 1935 and 1955.
The Nobel Prize that Egas Moniz received in 1949 will not be revoked. It stands in the record as a reminder that prestige and rigor are not the same thing, and that the difference between them, when it matters, matters enormously.
The Brain in History and Culture: Full Series
- Ancient Nootropics: What Egyptian, Greek, and Chinese Physicians Prescribed for Mental Acuity
- The History of Coffee — How the Most Widespread Cognitive Enhancer in History Changed Civilization
- Phrenology and Why Smart People Believed It for 150 Years
- The Lobotomy Era: How a Nobel Prize Was Awarded for One of Medicine’s Greatest Disasters — You are here
- How Soldiers in World War II Were Given Amphetamines As Standard Issue — and the Aftermath
- The History of Cocaine as a Legitimate Brain Medicine (and Freud’s Role in It)
- How the Discovery of Neurons Changed Everything We Thought We Knew About the Mind
- The Victorian Obsession With the Electric Brain — Early Attempts at Brain Stimulation